{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:48:32Z","timestamp":1788850112258,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071273"],"award-info":[{"award-number":["82071273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271906"],"award-info":[{"award-number":["82271906"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Myotonic dystrophy type 2 (DM2), caused by CCTG repeat expansion, is a common adult-onset disorder characterized by myotonia and progressive muscle degeneration with no effective treatment. Here, we identified Tyrosyl-DNA phosphodiesterase 1 (\n                    <jats:italic>TDP1<\/jats:italic>\n                    ) as a novel modifier for DM2 therapeutic intervention through a high-throughput chemical screening of 2160 compounds. Moreover, we detailed how both genetic and pharmacological inhibition of\n                    <jats:italic>TDP1<\/jats:italic>\n                    translates to a cascade of beneficial effects, including improved motor functions, amelioration of progressive muscle degeneration, repair of muscle fiber damage, and normalization of aberrant molecular pathology. Remarkably, the TDP1 inhibition led to substantial CCTG repeat contractions, a mechanism that underlies the observed muscle toxicity and neurodegeneration. Our results highlighted the potential of\n                    <jats:italic>TDP1<\/jats:italic>\n                    as a molecular target for addressing the complex interplay between repeat expansions and neuromuscular degeneration in DM2, hinting at broader applicability in a spectrum of repeat expansion disorders.\n                  <\/jats:p>","DOI":"10.1038\/s44321-025-00217-3","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:46:24Z","timestamp":1742942784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modulating CCTG repeat expansion toxicity in DM2 Drosophila model through TDP1 inhibition"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1949-1740","authenticated-orcid":false,"given":"Yingbao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6137-6659","authenticated-orcid":false,"given":"Peng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-4487","authenticated-orcid":false,"given":"Ranhui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"217_CR1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/hmg\/ddt524","volume":"23","author":"SS Barclay","year":"2014","unstructured":"Barclay SS, Tamura T, Ito H, Fujita K, Tagawa K, Shimamura T, Katsuta A, Shiwaku H, Sone M, Imoto S et al (2014) Systems biology analysis of Drosophila in vivo screen data elucidates core networks for DNA damage repair in SCA1. Hum Mol Genet 23:1345\u20131364","journal-title":"Hum Mol Genet"},{"key":"217_CR2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0026-895X(25)08586-4","volume":"47","author":"DR Beidler","year":"1995","unstructured":"Beidler DR, Cheng YC (1995) Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity. Mol Pharm 47:907\u2013914","journal-title":"Mol Pharm"},{"key":"217_CR3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/nar\/27.2.573","volume":"27","author":"G Benson","year":"1999","unstructured":"Benson G (1999) Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res 27:573\u2013580","journal-title":"Nucleic Acids Res"},{"key":"217_CR4","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2022.103277","volume":"111","author":"S Bhattacharjee","year":"2022","unstructured":"Bhattacharjee S, Rehman I, Nandy S, Das BB (2022) Post-translational regulation of Tyrosyl-DNA phosphodiesterase (TDP1 and TDP2) for the repair of the trapped topoisomerase-DNA covalent complex. DNA Repair 111:103277","journal-title":"DNA Repair"},{"key":"217_CR5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fneur.2019.00992","volume":"10","author":"F Bose","year":"2019","unstructured":"Bose F, Renna LV, Fossati B, Arpa G, Labate V, Milani V, Botta A, Micaglio E, Meola G, Cardani R (2019) TNNT2 missplicing in skeletal muscle as a cardiac biomarker in myotonic dystrophy type 1 but not in myotonic dystrophy type 2. Front Neurol 10:992","journal-title":"Front Neurol"},{"key":"217_CR6","doi-asserted-by":"crossref","first-page":"R786","DOI":"10.1016\/j.cub.2016.07.062","volume":"26","author":"I Bothe","year":"2016","unstructured":"Bothe I, Baylies MK (2016) Drosophila myogenesis. Curr Biol 26:R786\u2013791","journal-title":"Curr Biol"},{"key":"217_CR7","doi-asserted-by":"crossref","first-page":"12036","DOI":"10.1021\/acsomega.9b01142","volume":"4","author":"L Cai","year":"2019","unstructured":"Cai L, Qin X, Xu Z, Song Y, Jiang H, Wu Y, Ruan H, Chen J (2019) Comparison of cytotoxicity evaluation of anticancer drugs between real-time cell analysis and CCK-8 method. ACS Omega 4:12036\u201312042","journal-title":"ACS Omega"},{"key":"217_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02829-3","volume":"7","author":"E Cerro-Herreros","year":"2017","unstructured":"Cerro-Herreros E, Chakraborty M, Perez-Alonso M, Artero R, Llamusi B (2017) Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger myotonic dystrophy type 1-like phenotypes and activate autophagocytosis genes. Sci Rep 7:2843","journal-title":"Sci Rep"},{"key":"217_CR9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nchembio.78","volume":"4","author":"S Chang","year":"2008","unstructured":"Chang S, Bray SM, Li Z, Zarnescu DC, He C, Jin P, Warren ST (2008) Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 4:256\u2013263","journal-title":"Nat Chem Biol"},{"key":"217_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbadis.2006.05.013","volume":"1772","author":"DH Cho","year":"2007","unstructured":"Cho DH, Tapscott SJ (2007) Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 1772:195\u2013204","journal-title":"Biochim Biophys Acta"},{"key":"217_CR11","doi-asserted-by":"crossref","unstructured":"Chong CR, Chen X, Shi L, Liu JO, Sullivan DJ Jr (2006) A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol 2:415\u2013416","DOI":"10.1038\/nchembio806"},{"key":"217_CR12","doi-asserted-by":"crossref","unstructured":"Chong CR, Sullivan DJ Jr (2007) New uses for old drugs. Nature 448:645\u2013646","DOI":"10.1038\/448645a"},{"key":"217_CR13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3109\/03602532.2014.971957","volume":"46","author":"EQ Comeaux","year":"2014","unstructured":"Comeaux EQ, van Waardenburg RC (2014) Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target. Drug Metab Rev 46:494\u2013507","journal-title":"Drug Metab Rev"},{"key":"217_CR14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ajhg.2021.03.011","volume":"108","author":"C Depienne","year":"2021","unstructured":"Depienne C, Mandel JL (2021) 30 years of repeat expansion disorders: what have we learned and what are the remaining challenges? Am J Hum Genet 108:764\u2013785","journal-title":"Am J Hum Genet"},{"key":"217_CR15","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python Bindings. J Chem Inf Model 61:3891\u20133898","journal-title":"J Chem Inf Model"},{"key":"217_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature03314","volume":"434","author":"SF El-Khamisy","year":"2005","unstructured":"El-Khamisy SF, Saifi GM, Weinfeld M, Johansson F, Helleday T, Lupski JR, Caldecott KW (2005) Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434:108\u2013113","journal-title":"Nature"},{"key":"217_CR17","doi-asserted-by":"crossref","first-page":"11866","DOI":"10.1073\/pnas.1018213108","volume":"108","author":"A Garcia-Lopez","year":"2011","unstructured":"Garcia-Lopez A, Llamusi B, Orzaez M, Perez-Paya E, Artero RD (2011) In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models. Proc Natl Acad Sci USA 108:11866\u201311871","journal-title":"Proc Natl Acad Sci USA"},{"key":"217_CR18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.arcped.2017.09.029","volume":"25","author":"G Gousse","year":"2018","unstructured":"Gousse G, Patural H, Touraine R, Chabrier S, Rolland E, Antoine JC, Perrin L (2018) Lethal form of spinocerebellar ataxia type 7 with early onset in childhood. Arch Pediatr 25:42\u201344","journal-title":"Arch Pediatr"},{"key":"217_CR19","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1073\/pnas.1415011111","volume":"111","author":"D Guo","year":"2014","unstructured":"Guo D, Dexheimer TS, Pommier Y, Nash HA (2014) Neuroprotection and repair of 3\u2019-blocking DNA ends by glaikit (gkt) encoding Drosophila tyrosyl-DNA phosphodiesterase 1 (TDP1). Proc Natl Acad Sci USA 111:15816\u201315820","journal-title":"Proc Natl Acad Sci USA"},{"key":"217_CR20","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1212\/WNL.0000000000011002","volume":"96","author":"C Heatwole","year":"2021","unstructured":"Heatwole C, Luebbe E, Rosero S, Eichinger K, Martens W, Hilbert J, Dekdebrun J, Dilek N, Zizzi C, Johnson N et al (2021) Mexiletine in myotonic dystrophy type 1: a randomized, double-blind, placebo-controlled trial. Neurology 96:e228\u2013e240","journal-title":"Neurology"},{"key":"217_CR21","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1038\/sj.emboj.7601885","volume":"26","author":"R Hirano","year":"2007","unstructured":"Hirano R, Interthal H, Huang C, Nakamura T, Deguchi K, Choi K, Bhattacharjee MB, Arimura K, Umehara F, Izumo S et al (2007) Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation? EMBO J 26:4732\u20134743","journal-title":"EMBO J"},{"key":"217_CR22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","volume":"112","author":"J Horrigan","year":"2020","unstructured":"Horrigan J, Gomes TB, Snape M, Nikolenko N, McMorn A, Evans S, Yaroshinsky A, Della Pasqua O, Oosterholt S, Lochmuller H (2020) A phase 2 study of AMO-02 (Tideglusib) in congenital and childhood-onset myotonic dystrophy type 1 (DM1). Pediatr Neurol 112:84\u201393","journal-title":"Pediatr Neurol"},{"key":"217_CR23","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1021\/acs.jmedchem.1c00318","volume":"64","author":"DX Hu","year":"2021","unstructured":"Hu DX, Tang WL, Zhang Y, Yang H, Wang W, Agama K, Pommier Y, An LK (2021) Synthesis of methoxy-, methylenedioxy-, hydroxy-, and halo-substituted benzophenanthridinone derivatives as DNA topoisomerase IB (TOP1) and tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors and their biological activity for drug-resistant cancer. J Med Chem 64:7617\u20137629","journal-title":"J Med Chem"},{"key":"217_CR24","doi-asserted-by":"crossref","unstructured":"Hubert L Jr, Lin Y, Dion V, Wilson JH (2011) Topoisomerase 1 and single-strand break repair modulate transcription-induced CAG repeat contraction in human cells. Mol Cell Biol 31:3105\u20133112","DOI":"10.1128\/MCB.05158-11"},{"key":"217_CR25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bios.2013.04.019","volume":"48","author":"PW Jensen","year":"2013","unstructured":"Jensen PW, Falconi M, Kristoffersen EL, Simonsen AT, Cifuentes JB, Marcussen LB, Frohlich R, Vagner J, Harmsen C, Juul S et al (2013) Real-time detection of TDP1 activity using a fluorophore-quencher coupled DNA-biosensor. Biosens Bioelectron 48:230\u2013237","journal-title":"Biosens Bioelectron"},{"key":"217_CR26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41431-020-0601-4","volume":"28","author":"IBT Joosten","year":"2020","unstructured":"Joosten IBT, Hellebrekers D, de Greef BTA, Smeets HJM, de Die-Smulders CEM, Faber CG, Gerrits MM (2020) Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations. Eur J Hum Genet 28:956\u2013962","journal-title":"Eur J Hum Genet"},{"key":"217_CR27","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1038\/sj.emboj.7601869","volume":"26","author":"S Katyal","year":"2007","unstructured":"Katyal S, el-Khamisy SF, Russell HR, Li Y, Ju L, Caldecott KW, McKinnon PJ (2007) TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo. EMBO J 26:4720\u20134731","journal-title":"EMBO J"},{"key":"217_CR28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/embj.201284290","volume":"33","author":"P Klein","year":"2014","unstructured":"Klein P, Muller-Rischart AK, Motori E, Schonbauer C, Schnorrer F, Winklhofer KF, Klein R (2014) Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants. EMBO J 33:341\u2013355","journal-title":"EMBO J"},{"key":"217_CR29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.gene.2013.03.059","volume":"522","author":"A Kumar","year":"2013","unstructured":"Kumar A, Agarwal S, Agarwal D, Phadke SR (2013) Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder. Gene 522:226\u2013230","journal-title":"Gene"},{"key":"217_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77\u201379","journal-title":"Nature"},{"key":"217_CR31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcdb.2020.02.009","volume":"104","author":"Q Laurichesse","year":"2020","unstructured":"Laurichesse Q, Soler C (2020) Muscle development: a view from adult myogenesis in Drosophila. Semin Cell Dev Biol 104:39\u201350","journal-title":"Semin Cell Dev Biol"},{"key":"217_CR32","doi-asserted-by":"crossref","first-page":"e1006400","DOI":"10.1371\/journal.pgen.1006400","volume":"12","author":"KA Liao","year":"2016","unstructured":"Liao KA, Gonzalez-Morales N, Schock F (2016) Zasp52, a core Z-disc protein in Drosophila indirect flight muscles, interacts with alpha-actinin via an extended PDZ domain. PLoS Genet 12:e1006400","journal-title":"PLoS Genet"},{"key":"217_CR33","doi-asserted-by":"crossref","first-page":"e0232137","DOI":"10.1371\/journal.pone.0232137","volume":"15","author":"KA Liao","year":"2020","unstructured":"Liao KA, Gonzalez-Morales N, Schock F (2020) Characterizing the actin-binding ability of Zasp52 and its contribution to myofibril assembly. PLoS ONE 15:e0232137","journal-title":"PLoS ONE"},{"key":"217_CR34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1124\/mol.105.021865","volume":"70","author":"Z Liao","year":"2006","unstructured":"Liao Z, Thibaut L, Jobson A, Pommier Y (2006) Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors. Mol Pharm 70:366\u2013372","journal-title":"Mol Pharm"},{"key":"217_CR35","volume":"143","author":"Y Lin","year":"2020","unstructured":"Lin Y, Xue J, Deng J, He H, Luo S, Chen J, Li J, Yu L, Zhao J, Chen J et al (2020) Neddylation activity modulates the neurodegeneration associated with fragile X associated tremor\/ataxia syndrome (FXTAS) through regulating Sima. Neurobiol Dis 143:105013","journal-title":"Neurobiol Dis"},{"key":"217_CR36","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864\u2013867","journal-title":"Science"},{"key":"217_CR37","doi-asserted-by":"crossref","first-page":"10134","DOI":"10.1093\/nar\/gkz515","volume":"47","author":"GT Lountos","year":"2019","unstructured":"Lountos GT, Zhao XZ, Kiselev E, Tropea JE, Needle D, Pommier Y, Burke TR, Waugh DS (2019) Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening. Nucleic Acids Res 47:10134\u201310150","journal-title":"Nucleic Acids Res"},{"key":"217_CR38","first-page":"222","volume":"39","author":"G Meola","year":"2020","unstructured":"Meola G (2020) Myotonic dystrophy type 2: the 2020 update. Acta Myol 39:222\u2013234","journal-title":"Acta Myol"},{"key":"217_CR39","doi-asserted-by":"crossref","DOI":"10.1038\/srep11020","volume":"5","author":"R Nakatani","year":"2015","unstructured":"Nakatani R, Nakamori M, Fujimura H, Mochizuki H, Takahashi MP (2015) Large expansion of CTG*CAG repeats is exacerbated by MutSbeta in human cells. Sci Rep 5:11020","journal-title":"Sci Rep"},{"key":"217_CR40","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/ajmg.a.61165","volume":"179","author":"SL Nolin","year":"2019","unstructured":"Nolin SL, Glicksman A, Tortora N, Allen E, Macpherson J, Mila M, Vianna-Morgante AM, Sherman SL, Dobkin C, Latham GJ et al (2019) Expansions and contractions of the FMR1 CGG repeat in 5508 transmissions of normal, intermediate, and premutation alleles. Am J Med Genet A 179:1148\u20131156","journal-title":"Am J Med Genet A"},{"key":"217_CR41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.252.5009.1097","volume":"252","author":"I Oberle","year":"1991","unstructured":"Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097\u20131102","journal-title":"Science"},{"key":"217_CR42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2144\/96214bm08","volume":"21","author":"JM Ordway","year":"1996","unstructured":"Ordway JM, Detloff PJ (1996) In vitro synthesis and cloning of long CAG repeats. Biotechniques 21:609\u2013610","journal-title":"Biotechniques"},{"key":"217_CR43","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/brv.12674","volume":"96","author":"LL Ozimski","year":"2021","unstructured":"Ozimski LL, Sabater-Arcis M, Bargiela A, Artero R (2021) The hallmarks of myotonic dystrophy type 1 muscle dysfunction. Biol Rev Camb Philos Soc 96:716\u2013730","journal-title":"Biol Rev Camb Philos Soc"},{"key":"217_CR44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103489","volume":"28","author":"M Pascual-Gilabert","year":"2023","unstructured":"Pascual-Gilabert M, Artero R, Lopez-Castel A (2023) The myotonic dystrophy type 1 drug development pipeline: 2022 edition. Drug Discov Today 28:103489","journal-title":"Drug Discov Today"},{"key":"217_CR45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrg1689","volume":"6","author":"CE Pearson","year":"2005","unstructured":"Pearson CE, Nichol Edamura K, Cleary JD (2005) Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 6:729\u2013742","journal-title":"Nat Rev Genet"},{"key":"217_CR46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.dnarep.2014.03.020","volume":"19","author":"Y Pommier","year":"2014","unstructured":"Pommier Y, Huang SY, Gao R, Das BB, Murai J, Marchand C (2014) Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair ((Amst)) 19:114\u2013129","journal-title":"DNA Repair ((Amst))"},{"key":"217_CR47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","volume":"17","author":"Y Pommier","year":"2016","unstructured":"Pommier Y, Sun Y, Huang SN, Nitiss JL (2016) Roles of eukaryotic topoisomerases in transcription, replication and genomic stability. Nat Rev Mol Cell Biol 17:703\u2013721","journal-title":"Nat Rev Mol Cell Biol"},{"key":"217_CR48","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/hmg\/dds024","volume":"21","author":"A Qurashi","year":"2012","unstructured":"Qurashi A, Liu H, Ray L, Nelson DL, Duan R, Jin P (2012) Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila. Hum Mol Genet 21:2068\u20132075","journal-title":"Hum Mol Genet"},{"key":"217_CR49","unstructured":"Salih MAM, Takashima H, Boerkoel CF (2007) Spinocerebellar ataxia with axonal neuropathy type 1. In: Adam MP, Feldman J, Mirzaa GM, et al (eds) GeneReviews\u00ae. University of Washington, Seattle; 1993\u20132025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1105\/"},{"key":"217_CR50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10072-009-0048-4","volume":"30","author":"S Salvatori","year":"2009","unstructured":"Salvatori S, Furlan S, Fanin M, Picard A, Pastorello E, Romeo V, Trevisan CP, Angelini C (2009) Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2). Neurol Sci 30:185\u2013192","journal-title":"Neurol Sci"},{"key":"217_CR51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature08799","volume":"464","author":"F Schnorrer","year":"2010","unstructured":"Schnorrer F, Schonbauer C, Langer CC, Dietzl G, Novatchkova M, Schernhuber K, Fellner M, Azaryan A, Radolf M, Stark A et al (2010) Systematic genetic analysis of muscle morphogenesis and function in Drosophila. Nature 464:287\u2013291","journal-title":"Nature"},{"key":"217_CR52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04370-x","volume":"9","author":"C Sellier","year":"2018","unstructured":"Sellier C, Cerro-Herreros E, Blatter M, Freyermuth F, Gaucherot A, Ruffenach F, Sarkar P, Puymirat J, Udd B, Day JW et al (2018) rbFOX1\/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1\/type 2 differences. Nat Commun 9:2009","journal-title":"Nat Commun"},{"key":"217_CR53","doi-asserted-by":"crossref","first-page":"e16540","DOI":"10.7554\/eLife.16540","volume":"5","author":"A Shwartz","year":"2016","unstructured":"Shwartz A, Dhanyasi N, Schejter ED, Shilo BZ (2016) The Drosophila formin Fhos is a primary mediator of sarcomeric thin-filament array assembly. eLife 5:e16540","journal-title":"eLife"},{"key":"217_CR54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12041-014-0386-8","volume":"93","author":"SH Singh","year":"2014","unstructured":"Singh SH, Kumar P, Ramachandra NB, Nongthomba U (2014) Roles of the troponin isoforms during indirect flight muscle development in Drosophila. J Genet 93:379\u2013388","journal-title":"J Genet"},{"key":"217_CR55","first-page":"E8392","volume":"114","author":"XA Su","year":"2017","unstructured":"Su XA, Freudenreich CH (2017) Cytosine deamination and base excision repair cause R-loop-induced CAG repeat fragility and instability in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 114:E8392\u2013E8401","journal-title":"Proc Natl Acad Sci USA"},{"key":"217_CR56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/j.2040-4603.2018.tb00015.x","volume":"8","author":"JD Thomas","year":"2018","unstructured":"Thomas JD, Oliveira R, Sznajder LJ, Swanson MS (2018) Myotonic dystrophy and developmental regulation of RNA processing. Compr Physiol 8:509\u2013553","journal-title":"Compr Physiol"},{"key":"217_CR57","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.biocel.2013.06.010","volume":"45","author":"L Timchenko","year":"2013","unstructured":"Timchenko L (2013) Molecular mechanisms of muscle atrophy in myotonic dystrophies. Int J Biochem Cell Biol 45:2280\u20132287","journal-title":"Int J Biochem Cell Biol"},{"key":"217_CR58","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1007\/s12035-023-03531-4","volume":"60","author":"Y Wu","year":"2023","unstructured":"Wu Y, Song T, Xu Q (2023) R-LOOPs on short tandem repeat expansion disorders in neurodegenerative diseases. Mol Neurobiol 60:7185\u20137195","journal-title":"Mol Neurobiol"},{"key":"217_CR59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2014.05.026","volume":"69","author":"Y Yamashita","year":"2014","unstructured":"Yamashita Y, Matsuura T, Kurosaki T, Amakusa Y, Kinoshita M, Ibi T, Sahashi K, Ohno K (2014) LDB3 splicing abnormalities are specific to skeletal muscles of patients with myotonic dystrophy type 1 and alter its PKC binding affinity. Neurobiol Dis 69:200\u2013205","journal-title":"Neurobiol Dis"},{"key":"217_CR60","doi-asserted-by":"crossref","unstructured":"Yenigun VB, Sirito M, Amcheslavky A, Czernuszewicz T, Colonques-Bellmunt J, Garcia-Alcover I, Wojciechowska M, Bolduc C, Chen Z, Lopez Castel A et al (2017) (CCUG)(n) RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis. Dis Model Mech 10:993\u20131003","DOI":"10.1242\/dmm.026179"},{"key":"217_CR61","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/hmg\/ddu507","volume":"24","author":"Z Yu","year":"2015","unstructured":"Yu Z, Goodman LD, Shieh SY, Min M, Teng X, Zhu Y, Bonini NM (2015) A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL1. Hum Mol Genet 24:954\u2013962","journal-title":"Hum Mol Genet"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00217-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00217-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00217-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:42:38Z","timestamp":1786992158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00217-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,14]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00217-3","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"9"}}